Segirab-LS Capsule SR
Manufacturer
Selaginella Life Sciences
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Segirab-LS Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Segirab-LS Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole. It reduces excess acid production in the stomach and prevents the reflux of stomach acid into the food pipe. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Segirab-LS Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea, stomach pain, diarrhea, flatulence, constipation, headache, weakness, and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Segirab-LS Capsule SR.
Breastfeeding Warning
Information regarding the use of Segirab-LS Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Segirab-LS Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Segirab-LS Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
Do not consume alcohol while taking Segirab-LS Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Segirab-LS Capsule SR for longer than prescribed.
Related Medicines
Colosafe-L Capsule SR
Rabemac LS Capsule
Acera-L Capsule SR
Rablet L Capsules
Razo-L Capsule
Veloz L Capsule
Rabonik Plus Capsule SR
Ansuper-Plus Capsule SR
Raprazole L 75mg/20mg Capsule SR
Zolly LS 75mg/20mg Capsule SR
Frequently asked questions
What is the recommended timing for administering Segirab-LS Capsule SR?
Take Segirab-LS Capsule SR exactly as directed by your healthcare professional. It is best to take one capsule daily on an empty stomach.
Are there any specific patient groups that should not use Segirab-LS Capsule SR?
Patients with known allergies to any component or excipient of this medicine should avoid using Segirab-LS Capsule SR.
Can the use of Segirab-LS Capsule SR cause dizziness?
Yes, some patients taking Segirab-LS Capsule SR may experience dizziness (feeling faint, weak, unsteady or lightheaded). If you feel dizzy, it is recommended to rest and resume after feeling better.
Does using Segirab-LS Capsule SR increase the risk of fractures?
Some studies in adults suggest that treatment with Segirab-LS Capsule SR may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist or spine. The risk of fracture was higher in patients receiving high doses, which can mean multiple daily doses and long-term therapy (a year or longer).
Can I drive while taking Segirab-LS Capsule SR?
Segirab-LS Capsule SR may cause drowsiness, dizziness, or blurred vision. Therefore, it is not advisable to operate machinery or drive until you fully understand its effects on your body.
How should Segirab-LS Capsule SR be stored and disposed of?
Store this medicine in the original package or container, tightly closed. Follow the instructions mentioned on the label for storage. Do not dispose of the unused medication through regular waste streams. Ensure it is not consumed by pets, children, or other people.
